| Literature DB >> 34711214 |
Yu-Hsiang Su1, Yu-Ming Chang2, Chih-Ying Kung3, Chiu-Kuei Sung4, Wei-Shin Foo5, Mei-Hua Wu6, Shang-Jyh Chiou7.
Abstract
BACKGROUND: Aging reduces the quality and strength of bones and muscles and increases body fat, which can lead to the simultaneous occurrence of sarcopenia, osteopenia, and adiposity, a condition referred to as OsteoSarcopenic Adiposity (OSA). While previous studies have demonstrated that metabolic syndrome is associated with sarcopenia, osteopenia, and adiposity, the relationship between metabolic syndrome and OSA remains largely unknown.Entities:
Keywords: Metabolic syndrome; Multinomial logistic regression; Osteosarcopenic adiposity
Mesh:
Year: 2021 PMID: 34711214 PMCID: PMC8555223 DOI: 10.1186/s12902-021-00880-w
Source DB: PubMed Journal: BMC Endocr Disord ISSN: 1472-6823 Impact factor: 2.763
The basic characteristics with the distribution of response items among different OSA groups
| total | OSA = 0 | OSA = 1 | OSA = 2 | OSA = 3 | ||
|---|---|---|---|---|---|---|
| variables | n(%) | n(%) | n(%) | n(%) | n(%) | |
| Age | 58.55 ± 6.41 | 55.63 ± 5.3 | 57.88 ± 5.89 | 59.63 ± 6.43 | 64.72 ± 8.02 | < 0.001 |
| Sex Male | 1733(57.9) | 193(11.1) | 799(46.1) | 668(38.5.1) | 73(4.2) | < 0.001 |
| Female | 1258(42.1) | 176(14) | 624(49.6) | 390(31) | 68(5.4) | |
| Living status Alone | 207(6.9) | 26(12.6) | 89(43) | 81(39.1) | 11(5.3) | 0.563 |
| With families | 2784(93.1) | 343(12.3) | 1334(47.9) | 977(35.1) | 130(4.7) | |
| Employment Retired | 847(29.3) | 81(9.6) | 378(44.6) | 331(39.1) | 57(6.7) | 0.001 |
| Part-time | 390(13.5) | 52(13.3) | 187(47.9) | 137(35.1) | 14(3.6) | |
| Full-time | 1657(57.3) | 220(13.3) | 815(49.2) | 553(33.4) | 69(4.2) | |
| Exercise almost none | 600(20.4) | 57(9.5) | 266(44.3) | 237(39.5) | 40(6.7) | < 0.001 |
| walking or strolling | 1131(38.5) | 110(9.7) | 517(45.7) | 447(39.5) | 57(5) | |
| MIa exercise | 1206(41.1) | 195(16.2) | 614(50.9) | 355(29.4) | 42(3.5) | |
| Vitamin B No | 2210(73.9) | 278(12.6) | 1026(46.4) | 799(36.2) | 107(4.8) | 0.211 |
| Yes | 781(26.1) | 91(11.7) | 397(50.8) | 259(33.2) | 34(4.4) | |
| Vitamin D No | 2789(93.2) | 341(12.2) | 1313(47.1) | 1003(36) | 132(4.7) | 0.084 |
| Yes | 202(6.8) | 28(13.9) | 110(54.5) | 55(27.2) | 9(4.5) | |
| calcium tablets No | 2562(85.7) | 322(12.6) | 1211(47.3) | 908(35.4) | 121(4.7) | 0.763 |
| Yes | 429(14.3) | 47(11) | 212(49.4) | 150(35) | 20(4.7) | |
| Smoking No | 2385(80.3) | 288(12.1) | 1139(47.8) | 844(35.4) | 114(4.8) | 0.723 |
| Yes | 585(19.7) | 79(13.5) | 274(46.8) | 208(35.6) | 24(4.1) | |
| Hypertension No | 2221(74.3) | 307(13.8) | 1091(49.1) | 735(33.1) | 88(4) | < 0.001 |
| Yes | 770(25.7) | 62(8.1) | 332(43.1) | 323(41.9) | 53(6.9) | |
| Hyperlipidemia No | 2503(83.7) | 320(12.8) | 1214(48.5) | 852(34) | 117(4.7) | 0.005 |
| Yes | 488(16.3) | 49(10) | 209(42.8) | 206(42.2) | 24(4.9) | |
| Diabetes No | 2645(88.4) | 338(12.8) | 1265(47.8) | 922(34.9) | 120(4.5) | 0.067 |
| Yes | 346(11.6) | 31(9) | 158(45.7) | 136(39.3) | 21(6.1) | |
| CV diseases No | 2854(95.4) | 359(12.6) | 1370(48) | 997(34.9) | 128(4.5) | 0.001 |
| Yes | 137(4.6) | 10(7.3) | 53(38.7) | 61(44.5) | 13(9.5) | |
| metabolic syndrome No | 2319(77.5) | 322(13.9) | 1159(50) | 737(31.8) | 101(4.4) | < 0.001 |
| Yes | 672(22.5) | 47(7) | 264(39.3) | 321(47.8) | 40(6) |
CV: cardiovascular
OSA: osteosarcopenic adiposity
A: MI: moderate -intensity
the summary information in the relationship between metabolic syndrome and OSA from Multinomial logistic regression
| metabolic syndrome | OR (95% CI) | Adjusted OR (95% CI) | |||
|---|---|---|---|---|---|
| OR(95%CI) | Adjusted OR(95%CI) | ||||
| 1 vs 0 | Yes | 1.56(1.12–2.18) | .009 | 1.4(0.99–1.99) | 0.059 |
| 2 vs 0 | Yes | 2.98(2.14–4.16) | <.001 | 2.49(1.74–3.56) | <.001 |
| 3 vs 0 | Yes | 2.71(1.68–4.37) | <.001 | 2.57(1.52–4.34) | <.001 |
OSA: osteosarcopenic adiposity
OSA = 1: osteopenic or sarcopenic or adiposity
OSA = 2: osteosarcopenia or sarcopenic adiposity or osteopenic adiposity
OSA = 3: osteosarcopenic adiposity
the relationship between metabolic syndrome and OSA from Multinomial logistic regression
| 1 VS 0 | 2 VS 0 | 3 VS 0 | ||||
|---|---|---|---|---|---|---|
| Variables | AOR(95%CI) | AOR(95%CI) | AOR(95%CI) | |||
| Age | 1.08(1.05–1.11) | <.001 | 1.13(1.1–1.16) | <.001 | 1.26(1.22–1.31) | <.001 |
| Sex (ref: female) | ||||||
| male | 1.17(0.88–1.55) | .282 | 1.67(1.24–2.26) | .001 | 0.76(0.46–1.24) | .264 |
| Living status (ref: with families) | ||||||
| alone | 0.9(0.56–1.45) | .666 | 1.15(0.7–1.9) | .576 | 0.84(0.36–1.92) | .673 |
| Employment (ref: full-time) | ||||||
| Part-time | 0.82(0.57–1.17) | .271 | 0.8(0.55–1.18) | .263 | 0.42(0.21–0.85) | .016 |
| Retired | 0.98(0.71–1.35) | .882 | 1.17(0.83–1.64) | .375 | 0.64(0.38–1.09) | .102 |
| Exercise (ref.: moderate -intensity exercise) | ||||||
| walking or strolling | 1.49(1.13–1.95) | .004 | 2.21(1.65–2.95) | <.001 | 2.22(1.35–3.65) | .002 |
| almost none | 1.64(1.16–2.33) | .005 | 2.69(1.86–3.88) | <.001 | 3.98(2.23–7.08) | <.001 |
| Vitamin B (ref: Yes) | ||||||
| No | 0.83(0.62–1.1) | .186 | 0.94(0.69–1.27) | .678 | 1(0.6–1.65) | .987 |
| Vitamin D (ref: Yes) | ||||||
| No | 1.19(0.75–1.87) | .466 | 1.64(0.98–2.74) | .06 | 1.37(0.59–3.22) | .465 |
| calcium tablets (ref: Yes) | ||||||
| No | 0.91(0.63–1.29) | .584 | 0.95(0.65–1.38) | .786 | 1.15(0.62–2.14) | .65 |
| Smoking (ref: Yes) | ||||||
| No | 1.2(0.87–1.65) | .257 | 1.37(0.98–1.92) | .068 | 1.02(0.56–1.85) | .944 |
| Hypertension (ref: Yes) | ||||||
| No | 0.82(0.59–1.14) | .238 | 0.71(0.51–1) | .053 | 0.67(0.4–1.1) | .116 |
| Hyperlipidemia (ref: Yes) | ||||||
| No | 1.05(0.72–1.51) | .813 | 0.9(0.61–1.31) | .579 | 1.16(0.63–2.16) | .629 |
| Diabetes (ref: Yes) | ||||||
| No | 1.04(0.67–1.62) | .861 | 1.28(0.81–2.03) | .286 | 1.11(0.57–2.15) | .754 |
| CV disease (ref: Yes) | ||||||
| No | 1.02(0.5–2.08) | .947 | 0.81(0.39–1.65) | .554 | 0.55(0.21–1.41) | .212 |
| metabolic syndrome (ref: Yes) | ||||||
| No | 1.4(0.99–2) | .059 | 2.49(1.74–3.56) | <.001 | 2.57(1.52–4.34) | <.001 |
OSA = 1: osteopenic or sarcopenic or adiposity
OSA = 2: osteosarcopenia or sarcopenic adiposity or osteopenic adiposity
OSA = 3: osteosarcopenic adiposity
| Male | Female | |
|---|---|---|
| Mean ± SD | Mean ± SD | |
| Age | 58.76 ± 6.53 | 58.25 ± 6.23 |
| Grip strength | 38.47 ± 6.75 | 22.79 ± 4.2 |
| Body fat | 26.31 ± 5.44 | 33.47 ± 5.99 |
| BMD | −1.35 ± 0.97 | −1.68 ± 1.31 |
| BMI | 25.44 ± 3.04 | 23.28 ± 3.24 |
| SBP | 127.1 ± 13.66 | 123.05 ± 16.05 |
| DBP | 76.96 ± 9.87 | 70.94 ± 10.58 |
| WA | 90.85 ± 8.27 | 80.22 ± 8.18 |
| GLU-AC | 106.51 ± 25.89 | 100.22 ± 21.86 |
| TG | 136.47 ± 91.51 | 105.04 ± 62.51 |
| HDL-C | 48.32 ± 11.45 | 61.31 ± 15.23 |